Literature DB >> 7979399

Thyroid hormone rapidly induces hepatic LDL receptor mRNA levels in hypophysectomized rats.

G C Ness1, Z Zhao.   

Abstract

The effects of hypophysectomy and thyroid hormone treatment on the expression of the hepatic LDL receptor gene was studied in young male rats. Hypophysectomy lowered levels of LDL receptor mRNA and protein. It was found that increased levels of LDL receptor mRNA could be detected 30 min after giving hypophysectomized rats an intramuscular injection of 10 micrograms of L-triiodothyronine (T3) per 100 g of body weight. This dose of T3 also increased hepatic LDL receptor protein levels within 1 h. A T3 dose of only 0.25 microgram per 100 g increased LDL receptor mRNA levels more than threefold. The half-life of the hepatic LDL receptor mRNA was found to be about 30 min and was unaffected by T3. The data suggests that thyroid hormone acts physiologically to induce hepatic LDL receptor expression. This action may explain, in part, the hypocholesterolemic effect of the hormone.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979399     DOI: 10.1006/abbi.1994.1490

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  18 in total

Review 1.  GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.

Authors:  Amedeo Columbano; Grazia Chiellini; Marta Anna Kowalik
Journal:  Gene Expr       Date:  2017-06-13

2.  Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice.

Authors:  Lisen Johansson; Mats Rudling; Thomas S Scanlan; Thomas Lundåsen; Paul Webb; John Baxter; Bo Angelin; Paolo Parini
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

3.  Thyroid hormone enhances the ability of serum to accept cellular cholesterol via the ABCA1 transporter.

Authors:  Lindsey R Boone; William R Lagor; Margarita de la Llera Moya; Melissa I Niesen; George H Rothblat; Gene C Ness
Journal:  Atherosclerosis       Date:  2011-05-06       Impact factor: 5.162

4.  Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research.

Authors:  Kelsey E Jarrett; Ciaran Lee; Marco De Giorgi; Ayrea Hurley; Baiba K Gillard; Alexandria M Doerfler; Ang Li; Henry J Pownall; Gang Bao; William R Lagor
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

5.  Identification and functional characterization in vivo of a novel splice variant of LDLR in rhesus macaques.

Authors:  Sadik H Kassim; Luk H Vandenberghe; Ruben Hovhannisyan; James M Wilson; Daniel J Rader
Journal:  Physiol Genomics       Date:  2011-05-31       Impact factor: 3.107

6.  7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome.

Authors:  B U Fitzky; F F Moebius; H Asaoka; H Waage-Baudet; L Xu; G Xu; N Maeda; K Kluckman; S Hiller; H Yu; A K Batta; S Shefer; T Chen; G Salen; K Sulik; R D Simoni; G C Ness; H Glossmann; S B Patel; G S Tint
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

7.  Reduced hepatic sterol carrier protein-2 expression in the streptozotocin treated diabetic rat.

Authors:  M P McLean; K Nanjo; R B Irby; K J Warden; J T Billheimer
Journal:  Endocrine       Date:  1995-08       Impact factor: 3.633

8.  Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis.

Authors:  Sadik H Kassim; Hui Li; Luk H Vandenberghe; Christian Hinderer; Peter Bell; Dawn Marchadier; Aisha Wilson; Debra Cromley; Valeska Redon; Hongwei Yu; James M Wilson; Daniel J Rader
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

9.  Oxidized low-density lipoproteins impair endothelial function by inhibiting non-genomic action of thyroid hormone-mediated nitric oxide production in human endothelial cells.

Authors:  Roberto Vicinanza; Giuseppe Coppotelli; Carolina Malacrino; Tiziana Nardo; Barbara Buchetti; Luisa Lenti; Francesco S Celi; Susanna Scarpa
Journal:  Thyroid       Date:  2013-02       Impact factor: 6.568

10.  Regulation of pyruvate dehydrogenase kinase 4 (PDK4) by thyroid hormone: role of the peroxisome proliferator-activated receptor gamma coactivator (PGC-1 alpha).

Authors:  Ramy R Attia; Sara Connnaughton; Lindsey R Boone; Fang Wang; Marshall B Elam; Gene C Ness; George A Cook; Edwards A Park
Journal:  J Biol Chem       Date:  2009-11-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.